End-of-day quote
Korea S.E.
18:00:00 2024-05-16 EDT
|
5-day change
|
1st Jan Change
|
27,000
KRW
|
-4.59%
|
|
-6.09%
|
+9.31%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
178,559
|
406,916
|
679,386
|
489,358
|
288,614
|
352,910
|
Enterprise Value (EV)
1 |
204,750
|
434,830
|
720,497
|
604,147
|
410,556
|
533,770
|
P/E ratio
|
6.19
x
|
8.83
x
|
14.7
x
|
26.4
x
|
6.17
x
|
-20.2
x
|
Yield
|
0.8%
|
0.52%
|
0.31%
|
0.44%
|
0.74%
|
0.2%
|
Capitalization / Revenue
|
0.42
x
|
0.85
x
|
1.4
x
|
0.94
x
|
0.42
x
|
0.61
x
|
EV / Revenue
|
0.48
x
|
0.9
x
|
1.48
x
|
1.16
x
|
0.6
x
|
0.93
x
|
EV / EBITDA
|
4.08
x
|
5.42
x
|
8.22
x
|
10.9
x
|
4.05
x
|
7.92
x
|
EV / FCF
|
-7.89
x
|
34
x
|
-37.7
x
|
-11.5
x
|
71
x
|
-9.97
x
|
FCF Yield
|
-12.7%
|
2.94%
|
-2.65%
|
-8.73%
|
1.41%
|
-10%
|
Price to Book
|
0.81
x
|
1.53
x
|
2.19
x
|
1.47
x
|
0.76
x
|
0.98
x
|
Nbr of stocks (in thousands)
|
14,228
|
14,228
|
14,258
|
14,288
|
14,288
|
14,288
|
Reference price
2 |
12,550
|
28,600
|
47,650
|
34,250
|
20,200
|
24,700
|
Announcement Date
|
19-03-15
|
20-03-13
|
21-03-22
|
22-03-21
|
23-03-21
|
24-03-18
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
425,448
|
481,013
|
486,607
|
521,796
|
680,207
|
574,762
|
EBITDA
1 |
50,154
|
80,166
|
87,671
|
55,442
|
101,473
|
67,377
|
EBIT
1 |
35,608
|
59,643
|
63,488
|
26,004
|
64,642
|
24,700
|
Operating Margin
|
8.37%
|
12.4%
|
13.05%
|
4.98%
|
9.5%
|
4.3%
|
Earnings before Tax (EBT)
1 |
38,234
|
59,172
|
63,370
|
29,192
|
63,819
|
-19,823
|
Net income
1 |
28,797
|
46,085
|
46,215
|
18,517
|
46,805
|
-17,493
|
Net margin
|
6.77%
|
9.58%
|
9.5%
|
3.55%
|
6.88%
|
-3.04%
|
EPS
2 |
2,026
|
3,239
|
3,242
|
1,296
|
3,276
|
-1,224
|
Free Cash Flow
1 |
-25,960
|
12,772
|
-19,125
|
-52,753
|
5,784
|
-53,547
|
FCF margin
|
-6.1%
|
2.66%
|
-3.93%
|
-10.11%
|
0.85%
|
-9.32%
|
FCF Conversion (EBITDA)
|
-
|
15.93%
|
-
|
-
|
5.7%
|
-
|
FCF Conversion (Net income)
|
-
|
27.71%
|
-
|
-
|
12.36%
|
-
|
Dividend per Share
2 |
100.0
|
150.0
|
150.0
|
150.0
|
150.0
|
50.00
|
Announcement Date
|
19-03-15
|
20-03-13
|
21-03-22
|
22-03-21
|
23-03-21
|
24-03-18
|
Fiscal Period: December |
2021 Q3
|
2023 Q1
|
---|
Net sales
|
137.4
|
-
|
EBITDA
|
-
|
-
|
EBIT
|
13.19
|
-
|
Operating Margin
|
9.6%
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
Net income
1 |
-
|
4.889
|
Net margin
|
-
|
-
|
EPS
2 |
-
|
342.0
|
Dividend per Share
|
-
|
-
|
Announcement Date
|
21-11-15
|
23-05-15
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
26,191
|
27,914
|
41,112
|
114,788
|
121,941
|
180,861
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.5222
x
|
0.3482
x
|
0.4689
x
|
2.07
x
|
1.202
x
|
2.684
x
|
Free Cash Flow
1 |
-25,960
|
12,772
|
-19,125
|
-52,753
|
5,784
|
-53,547
|
ROE (net income / shareholders' equity)
|
14%
|
18.9%
|
16.3%
|
5.45%
|
12.2%
|
-6.13%
|
ROA (Net income/ Total Assets)
|
7.73%
|
10.7%
|
9.34%
|
3.11%
|
6.49%
|
2.34%
|
Assets
1 |
372,572
|
430,781
|
494,816
|
596,038
|
721,227
|
-748,362
|
Book Value Per Share
2 |
15,585
|
18,688
|
21,710
|
23,281
|
26,565
|
25,207
|
Cash Flow per Share
2 |
888.0
|
1,667
|
3,318
|
3,167
|
4,186
|
3,246
|
Capex
1 |
43,571
|
43,476
|
84,455
|
64,040
|
51,663
|
106,268
|
Capex / Sales
|
10.24%
|
9.04%
|
17.36%
|
12.27%
|
7.6%
|
18.49%
|
Announcement Date
|
19-03-15
|
20-03-13
|
21-03-22
|
22-03-21
|
23-03-21
|
24-03-18
|
|
1st Jan change
|
Capi.
|
---|
| +9.31% | 300M | | +17.62% | 66.43B | | +2.92% | 49.89B | | +19.98% | 41.88B | | +20.88% | 26.48B | | +12.04% | 19.68B | | +1.20% | 17B | | -22.98% | 16.12B | | +2.77% | 15.28B | | -8.96% | 15.18B |
Other Specialty Chemicals
|